Biology Technology
Dates Announced for IntertechPira's 5th Annual Biopolymers Symposium
| 2/9/2010 | Conference will be held October 11-13, 2010 in Denver, CO. Portland, ME (PRWEB) February 9, 2010 -- IntertechPira is pleased to announce the 5th annual Biopolymers Symposium 2010, scheduled for October 11-13, 2010 at The Westin Tabor Center in Denver, CO, US. This year's program will bring together important players, key innovators and decisi... [Comments] |
| 2/9/2010 | NEW YORK , Feb. 9 Reportlinker.com announces that a new market research report is available in its catalogue: The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) http://www.reportlinker.com/p0176223/The-Clinical-Laboratory-Services-Market-Growth-Opportunities-Competitive... [Comments] |
Reportlinker Adds SNP Genotyping and Analysis Markets
| 2/9/2010 | NEW YORK , Feb. 9 Reportlinker.com announces that a new market research report is available in its catalogue: SNP Genotyping and Analysis Markets http://www.reportlinker.com/p0176225/SNP-Genotyping-and-Analysis-Markets.html Because SNPs (single nucleotide polymorphisms),are the most common type of genetic variation betw... [Comments] |
endpoint Saves Money and Time for Medical Research Teams Through PULSE
| 2/9/2010 | SAN FRANCISCO , Feb. 9 endpoint Clinical ( www.endpointclinical.com ), a leader in Integrated Voice Response (IVR)/Integrated Web Response (IWR) systems, announced today that PULSE, a fully configurable platform that allows users to design and deploy clinical trial Integrated Response Technology (IRT) systems, saves 40 percent on the development time of c... [Comments] |
Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
| 2/9/2010 | SAN DIEGO , Feb. 9 Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced that Felix J. Baker , Ph.D., has been appointed to the Company's Board of Directors. Dr. Baker is a managing partner of Baker Bros. Advisors, LLC, the manager and advisor to the funds of Baker Brothers Investments, Ardea's largest shareholder. "Ardea's impr... [Comments] |
| 2/9/2010 | CHENGDU, China , Feb. 9 /PRNewswire-Asia-FirstCall/ -- TianyinPharmaceutical Co., Inc., (NYSE Amex: TPI ), a manufacturer and supplier ofmodernized traditional Chinese medicine ("TCM") and Western Pharmaceuticalsbased in Chengdu, China , today announced that it expects operational benefitsfrom the recently published Guide to Reform of Pricing Mechanism... [Comments] |
Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps
| 2/9/2010 | PEORIA, Ariz. , Feb. 9 A leading clinical research center in Peoria has joined an international research program to study an investigational drug designed as a possible treatment for painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States . Although not life threatening,... [Comments] |
New Funding Validates Importance of Divergence's Work on Nematodes
| 2/9/2010 | Divergence receives grant funding of $500,000 to prevent crop damage by nematodes as the Divergence and National Corn Growers Association continues collaboration. (PRWEB) February 9, 2010 -- Divergence, Inc. announced today that the company has recently received two Small Business Innovation Research (SBIR) grants totaling $500,000, along with... [Comments] |
| 2/9/2010 | SILVER SPRING, Md. , Feb. 9 United Therapeutics Corporation (Nasdaq: UTHR ) announced today that it will release its fourth quarter and annual 2009 financial results before market open on Tuesday, February 16, 2010 . United Therapeutics will host a half-hour teleconference on Tuesday, February 16, 2010 , at 9:00 a.m. Eastern Time . ... [Comments] |
| 2/9/2010 | HUNTINGTON BEACH, California and AMSTERDAM , February 9 Agendia, a world leader in molecular cancer diagnostics, announced today thatit has received the Clinical Laboratory Permit from the New York State Department of Health. The New York State permit allows the company to receivecommercial samples of MammaPrint, its FDA-cleared breast cancer recur... [Comments] |
(Date:2/8/2010)... Cellular imaging offers a wealth of data about how ... study biological systems is a daunting challenge. In ... ( www.genome.org ), researchers have developed a novel method ... interactions within biological networks, offering a glimpse into the ... scientists have been peering through a microscope at cells ...
(Date:2/8/2010)... third-hand smoke, the residue from tobacco smoke that ... cigarette has been extinguished, reacts with the common ... carcinogens. This new potential health hazard was revealed ... the Lawrence Berkeley National Laboratory (Berkeley Lab). , ... form of a vapor that adsorbs strongly onto ...
(Date:2/8/2010)... to a significantly elevated risk of having a child ... an exhaustive study of all births in California during ... paternal age is associated with elevated autism risk only ... under 30, the study found. , Published online today ... Research, the study, "Independent and Dependent Contributions of ...
Breaking Biology News(10 mins):Method of the future uses single-cell imaging to identify gene interactions 2Study reveals new details on the dangers of third-hand smoke 2Study reveals new details on the dangers of third-hand smoke 3Study reveals new details on the dangers of third-hand smoke 4UC Davis study confirms link between advanced maternal age and autism 2UC Davis study confirms link between advanced maternal age and autism 3UC Davis study confirms link between advanced maternal age and autism 4Americas Silent Crisis 3A Addiction Downturn Fuels Rising Drug and Alcohol Abuse Phoenix House Study Reveals 49777 1Americas Silent Crisis 3A Addiction Downturn Fuels Rising Drug and Alcohol Abuse Phoenix House Study Reveals 49777 2Americas Silent Crisis 3A Addiction Downturn Fuels Rising Drug and Alcohol Abuse Phoenix House Study Reveals 49777 3Meckels diverticulum masked by intermittent recurrent subocclusive episodes 49773 1Lack of happiness hormone serotonin in the brain causes impaired maternal behavior in mice 8972 1... in the ESA journals Frontiers in Ecology and the ... Ecological Monographs . , 1. Fuel removal ... , Ecological Applications , ... methods under the U.S. National Fire and Fire Surrogate Study. ...
... growing food in northern Ghana difficult enough. It doesn,t help ... available to power tractors for planting crops or to power ... the seeds from some native trees may be able to ... Ghana to create biodiesel from the seeds of trees that ...
... Exxon Valdez oil spill devastated a vast stretch of the ... unable to effectively manage a large oil spill, according to ... anniversary of the Exxon Valdez spill approaches on March 24, ... oil development in the Arctic until technologies improve to ensure ...
Other Biology News:Highlights from the March editions of ESA journals 2Highlights from the March editions of ESA journals 3K-State researchers work with university in Ghana to create biofuels from native tree seeds 2Arctic governments and industry still unprepared for oil spills 20 years after Exxon Valdez 2Arctic governments and industry still unprepared for oil spills 20 years after Exxon Valdez 3... serum is collected from fasted Beagle canines of ... Available Anticoagulants: N-02: Citrate ... N-08: Potassium Oxalate N-10: ... ACD N-07: CPD N-09: ...
Collected from normal, healthy animals in carefully maintained standing herds of US orgin. Pricing: $45/unit for 1 - 10 units...
Ready-to-use; 40mg/ml X-Gal and 32mg/ml IPTG...
GOAT ANTI PPP2R5B...
Biology Products:(Date:2/8/2010)... Feb. 8 /PRNewswire-FirstCall/ - YM BioSciences ... operational and financial results for the second quarter ... . ,, "After rigorous evaluation of numerous global ... a clinical-stage, Melbourne -based drug development company, ... David Allan , Chairman & CEO of YM ...
(Date:2/8/2010)... Feb. 8 Corgenix Medical Corporation (OTC ... diagnostic test kits, and Tulane University , today ... combat viral hemorrhagic fever (VHF), an effort that will ... for Corgenix over the life of the contract. ... a five-year contract totaling $15,224,927 to ...
(Date:2/8/2010)... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... Ph.D. to its Board of Directors effective immediately. He ... Receptos, Inc., and former Executive Chairman of Biogen Idec, ... Bill Rastetter to our Board of Directors," said ... Board of Neurocrine Biosciences. "The company is very fortunate ...
(Date:2/5/2010)... test to find undetected landmines. , Students from the ... glows green when it comes into contact with chemicals ... mixed into a colourless solution that, when sprayed on ... presence of landmines. , Researchers say that the ... from the air onto areas thought to contain landmines, ...
Breaking Biology Technology:YM BioSciences reports second quarter 2010 operational and financial results 2YM BioSciences reports second quarter 2010 operational and financial results 3YM BioSciences reports second quarter 2010 operational and financial results 4YM BioSciences reports second quarter 2010 operational and financial results 5YM BioSciences reports second quarter 2010 operational and financial results 6YM BioSciences reports second quarter 2010 operational and financial results 7YM BioSciences reports second quarter 2010 operational and financial results 8YM BioSciences reports second quarter 2010 operational and financial results 9YM BioSciences reports second quarter 2010 operational and financial results 10YM BioSciences reports second quarter 2010 operational and financial results 11YM BioSciences reports second quarter 2010 operational and financial results 12Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors 2[0] YM BioSciences reports second quarter 2010 operational and financial results[0] Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents[0] Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors[0] Simple test could offer cheap solution to detecting landmines
... Care managers can now quickly and easily access ... environment of care (EC) compliance with the ... interviews with EC experts called "EC Bits."EC Bits audio ... feature expert advice to help keep EC managers ...
... CITY, Calif., Feb. 24 Pearl Therapeutics announced,today that ... Oxford,Finance Corporation and Silicon Valley Bank, a member ... provided the capital which will be drawn in two,tranches. ... to be working with Oxford and SVB. They ...
... Feb. 24 Novasys Medical, Inc., a ... today that Noridian,Administrative Services, LLC, a regional ... now covering the non-surgical Renessa treatment,for women ... currently,administers benefits for approximately 4 million Medicare ...
Other Biology Technology:Web-based Audio Interviews Keep Environment of Care Managers Up-to-Date on Key EC Compliance Issues 2Pearl Therapeutics Secures $8 Million in Debt Financing 2Pearl Therapeutics Secures $8 Million in Debt Financing 3Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |